NASDAQ:DMAC

Diamedica Therapeutics Stock Predictions

etoro logo Buy DMAC
*Your capital is at risk
$5.65
-0.120 (-2.08%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

DMAC Prediction Chart

DMAC Predictions History

Latest community submissions for DMAC.
Predictor Target Session Target Price Result Direction Accuracy Score
Jun 27, 2023 $4.27 -3.06% $4.25 V 99.64% 5
Jun 27, 2023 $4.32 -1.91% $4.25 V 98.45% 1
JS JS Pro
Jun 26, 2023 $4.35 +2.35% $4.40 V 98.86% 2
Jun 26, 2023 $4.12 -3.05% $4.40 X 93.65% 0
Jun 26, 2023 $4.17 -1.91% $4.40 X 94.75% 0
JS JS Pro
Jun 22, 2023 $3.49 -4.12% $4.05 X 86.17% 0
Jun 22, 2023 $3.52 -3.35% $4.05 X 86.86% 0
Jun 22, 2023 $3.56 -2.09% $4.05 X 87.99% 0
AlexVel AlexVel Pro
Jun 22, 2023 $3.72 +2.20% $4.05 V 91.85% 1
Jun 14, 2023 $3.14 -3.25% $3.16 V 99.51% 5
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for DMAC with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT DIAMEDICA THERAPEUTICS INC.
DiaMedica Therapeutics
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type I or Type II diabetes; and Phase 2/3 REMEDY2 trials for the treatment of patients with acute ischemic ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE